ConCallIQ
Go Pro
AETHER Diversified 15 Jan 2026

Aether Industries Limited — Q3 FY26

Aether Industries delivered a strong Q3 FY26 with consolidated revenue of ₹317.1 crore (+44% YoY) and EBITDA of ₹108.3 crore (+75% YoY), driven by robust volume growth in large-scale manufacturing (25% YoY) and ramp-up in contract manufacturing.

bullish high
Compare with...
Revenue ₹317 Cr +44%
EBITDA ₹108 Cr +75%
PAT ₹65 Cr +49%
EBITDA Margin 34% +600bps
Duration 62 min
Read Time 1 min read

Financial stats pending filing verification

2-Minute Summary

✦ AI-Generated from Full Transcript

Aether Industries delivered a strong Q3 FY26 with consolidated revenue of ₹317.1 crore (+44% YoY) and EBITDA of ₹108.3 crore (+75% YoY), driven by robust volume growth in large-scale manufacturing (25% YoY) and ramp-up in contract manufacturing. EBITDA margin expanded 600 bps YoY to 34%, aided by operating leverage and a one-time insurance claim. Management highlighted completion of Site 3+ and first two blocks of Site 5, with commercial production imminent. The company added five new clients and three new LSM products. Guidance includes 70% revenue from CRAMS/CM over time, with near-term capacity utilization targets of 45-50% for new sites. Key risk: working capital days increased to 160 due to inventory buildup for new sites, though management expects improvement as CM share rises.

Risks4 trackedTranscriptfull text
Research workspace

Focused Modules

!Risks 4 risks

Risk Intelligence

Working capital days elevated due to inventory buildup

View Risks →
Transcript Full text

Call Transcript

Full transcript text is available on this route.

Read Transcript →

Quarter Snapshot

Large-scale manufacturing volume growth 25%
+25% YoY

Volume growth in LSM vertical was over 25% year-on-year, indicating strong demand.

Site 4 sales ₹60 crore
+20% QoQ

Sales from Site 4 increased 20% quarter-on-quarter to ₹60 crore, driven by Baker Hughes contract.

CRAMS/CM revenue share 43%
N/A

43% of sales came from contract exclusive manufacturing, with CRAMS at 8% and LSM at 41%.

Export revenue share 36%
N/A

Export revenue stood at 36% of total revenue, with domestic at 64%.

Fast read

Guidance and risk preview

Top guidance Site 3+ and Site 5 commercial production in Q4 FY26

Commercial production from Site 3+ and first two blocks of Site 5 will commence shortly, with water/solvent trials already started.

Top risk Working capital days elevated due to inventory buildup

Net working capital cycle increased to 160 days from 149 days as of September 2025, mainly due to inventory buildup for new sites.

View Risks →